+44 115 974 9000
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world
We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
Will you be going to #SACHS_BEF19 in Basel this year - from 25-26 September?— Quotient Sciences (@Quotient_Sci) September 5, 2019
David Ross will be attending and you can get in touch with him directly to schedule a meeting
#SACHS #Basel #CDMO #CRO #Formulation #Manufacturing #SmallMolecules #DrugDevelopment #QuotientSciences pic.twitter.com/t6168IMF8P
Tonix has dosed participants in a Phase 1 study evaluating the safety, tolerability and pharmacokinetics of TNX-601 (tianeptine oxalate) for the daytime treatment of #PTSD. Topline data is expected later this year. Learn more: https://t.co/TsqGkPRMPx $TNXP— Tonix Pharma (@TonixPharma) September 4, 2019